- Home
- CASI vs FBLG Comparison
CASI vs FBLG Comparison
Compare CASI & FBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CASI
- FBLG
- Stock Information
- Founded
- CASI 1991
- FBLG 2021
- Country
- CASI China
- FBLG United States
- Employees
- CASI N/A
- FBLG N/A
- Industry
- CASI Biotechnology: Pharmaceutical Preparations
- FBLG
- Sector
- CASI Health Care
- FBLG
- Exchange
- CASI Nasdaq
- FBLG NYSE
- Market Cap
- CASI 35.0M
- FBLG 41.5M
- IPO Year
- CASI 1996
- FBLG 2024
- Fundamental
- Price
- CASI $2.21
- FBLG $1.10
- Analyst Decision
- CASI Strong Buy
- FBLG Strong Buy
- Analyst Count
- CASI 1
- FBLG 4
- Target Price
- CASI $6.00
- FBLG $13.00
- AVG Volume (30 Days)
- CASI 8.1K
- FBLG 426.5K
- Earning Date
- CASI 03-27-2025
- FBLG 03-25-2025
- Dividend Yield
- CASI N/A
- FBLG N/A
- EPS Growth
- CASI N/A
- FBLG N/A
- EPS
- CASI N/A
- FBLG N/A
- Revenue
- CASI $22,055,000.00
- FBLG N/A
- Revenue This Year
- CASI N/A
- FBLG N/A
- Revenue Next Year
- CASI $134.79
- FBLG N/A
- P/E Ratio
- CASI N/A
- FBLG N/A
- Revenue Growth
- CASI N/A
- FBLG N/A
- 52 Week Low
- CASI $2.04
- FBLG $0.98
- 52 Week High
- CASI $7.67
- FBLG $13.59
- Technical
- Relative Strength Index (RSI)
- CASI 35.91
- FBLG 39.02
- Support Level
- CASI $2.15
- FBLG $1.05
- Resistance Level
- CASI $2.49
- FBLG $1.25
- Average True Range (ATR)
- CASI 0.15
- FBLG 0.14
- MACD
- CASI 0.00
- FBLG 0.02
- Stochastic Oscillator
- CASI 35.42
- FBLG 37.91
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.
About FBLG FIBROBIOLOGICS INC
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.